Your position:
m.limatoxi.com
>>
EN
>>
EN
>>
Pharmaceutical News
>>
Lu Kang Pharmaceutical achieved an operating income of 6.147 billion yuan in 2023, a year-on-year increase of 9.34%.
>> article
Lu Kang Pharmaceutical achieved an operating income of 6.147 billion yuan in 2023, a year-on-year increase of 9.34%.
Editor:xuezhe Clicks:
0
Date:2024-5-11 15:03:38
Keyword:
Lu Kang Pharmaceutical
Healthoo Information:
UserLogin
UserName：
Password：
The non-formal user may read the summary, the formal user can read the whole article。
please at once register the user of Heatlhoo.com
After registration, we will provide the sample reports and the more comprehensive consulting services for you.
UserName
Contact:
Title:
Mr.
Ms.
Password
Repeat password:
Mobile
Email
Verification code:
Company Name
E-mail:xuezhe@healthoo.com
Tel.:86-10-68032463
Our services:
China Im\Ex data service
Service fees of Chinese Vision
Our service items
Online information introduction
Monthly information
Relative Information
Pharmaceuticals export grows 6.8% in January
The latest price of inositol in Zhucheng Haotian Pharmaceutical Co., L...
Luwei Pharmaceutical Group invested in the construction of food-grade ...
Zhejiang Pharmaceutical Changhai Bio-branch released the shutdown main...
Common pharmaceutical industry: the price inflection point of steroid ...
Guantianxia Biotechnology Companys annual output of 5,000 tons of bio-...
From quinolones to new small molecular targeted drugs, intermediates o...
Novo Nordisk halts phase III FLOW trial of semaglutide early due to st...
Churun Chemical invested in new pharmaceutical intermediates projects ...
Jiangxi Tianxin Pharmaceutical was overhauled in the summer of 2023, t...
Address: Suite 13F,NO2 Building, FuXing International, TianHua North Street, Yizhuang, Daxing District, Beijing, P.R. China
Tel:+86-10-68032463
map
